Pharmaceutically acceptable salt, enantiomer, stereoisomer, rotamer. tautomer, diastereomer, atropisomer or racemate thereof, including the pyridine NOXIDE thereof of 4 substituted aminothiazole compound

PK201200194A0Undetermined Publication Date: 2012-05-02NOVARTIS AG
0 Cites 0 Cited by

Patent Information

Application Number
PK201200194
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Filing Date
2012-03-27
Publication Date
2012-05-02
Patent Text Reader

Abstract

The present application describes a pharmaceutically acceptable salt, enantiomer, stereoisomer, rotamer, tautomer, diastereomer, atropisomer or racemate thereof, including the pyridine N-oxide thereof, of a compound of the general Formula VI:wherein R, R2 , R2a, R3 , R4a, R4b, R5 and R12 have meanings as defined in the specification. Also disclosed is a pharmaceutical composition comprising the salt of said compound for use in the treatment of bacterial infection.
Need to check novelty before this filing date? Find Prior Art